Dextromethorphan/Methadone

右美沙芬/美沙酮

Report date: 2025/10/24 20:00:54

Base Information

Drug NameDextromethorphan/Methadone
Drug Alias Name美沙酮/右美沙芬Dextromethorphan and MethadoneMethadone/Dextromethorphan美沙酮右美沙芬Methadone and Dextromethorphan +[7] 
ClassificationSmall molecules
Mechanisms of ActionOpioid receptors agonistsGlutamate [NMDA] receptor antagonists
TargetsOpioid receptorsGlutamate [NMDA] receptor
Therapy Area/IndicationsHeroin DependenceSevere Combined ImmunodeficiencyBone Marrow Failure Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Dextromethorphan HydrobromideMethadone Hydrochloride
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical CenterEndo International Plc
Active IndicationsN/A
Inactive IndicationsHeroin DependenceSevere Combined ImmunodeficiencyBone Marrow Failure Disorders +[5] 

Other Information

ATC CodeN/A
Related LinksN/A